查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1813930

美國雇主和職場藥物檢測市場規模、佔有率和趨勢分析報告：按類型、產品、模式、藥物、最終用途和細分預測，2025-2033 年

U.S. Employer And Workplace Drug Testing Market Size, Share & Trends Analysis Report By Type (Pre-employment Drug Screens, Post-employment), By Product, By Mode, By Drug, By End-use (IT/Finance, Manufacturing), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

市場規模與趨勢：

預計 2024 年美國雇主和職場藥物檢測市場價值將達到 25.7 億美元，到 2033 年將達到 40.1 億美元，2025 年至 2033 年的複合年成長率為 5.2%。

這個市場的主要驅動力在於嚴格的職場安全法規、日益增強的藥物濫用風險意識，以及各行各業日益推行的預防性篩檢措施。藥物檢測計畫被廣泛實施，用於檢測非法藥物的存在和處方藥的濫用情況，而全面的篩檢通訊協定有助於遵守聯邦和州政府的要求，提高生產力，並減少職場事故。

隨著快速檢測套組、實驗室檢測和口腔液體檢測方法的改進，職場對職場前和隨機檢測的需求日益成長。數位化結果系統和自動化報告使這項流程更快、更準確，使雇主能夠快速做出招募決策並更有效地監控員工。此外，多個州大麻法律的變化促使主要企業調整其檢測政策，以滿足合規需求和不斷變化的法律標準。

根據美國成癮中心2024年進行的全國性調查，15.3%的美國勞工承認曾在酒精影響下工作，2.9%的勞工承認曾在非法藥物影響下工作。這凸顯了雇主面臨的持續挑戰，並凸顯了製定強力的藥物檢測政策以保障職場安全和生產力的必要性。

患有物質使用障礙 (SUD) 的員工數量不斷增加，使得職場的藥物檢測變得更加重要。藥物濫用會導致生產力下降、缺勤率上升和盛行率上升。它還會降低員工士氣，增加工作場所事故和傷害的風險，每年對美國企業造成數十億美元的損失。這些因素預計將推動美國各地雇主和職場對藥物檢測服務的需求。

總體而言，美國雇主和職場藥物檢測市場正在經歷穩定的技術創新，旨在提高速度、準確性和易用性。檢測方法、數位化結果管理和分析工具的進步正在幫助雇主簡化篩檢流程，同時確保遵守不斷變化的法規。在雲端基礎和人工智慧主導的分析支援下，多面板和口腔液體檢測的採用，有助於檢測更廣泛的物質並及早發現潛在問題。這些技術創新預計將在未來幾年加強職場安全計劃，並支持更有效的勞動力管理。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國雇主和職場藥物測試市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/輔助市場前景。
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國雇主和職場藥物測試市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章美國雇主和職場藥物測試市場：類型估計和趨勢分析

  • 細分儀表板
  • 美國雇主與職場藥物檢測市場波動分析
  • 美國雇主和職場藥物檢測市場規模和趨勢分析（按類型）（2021-2033）
  • 就業前藥物測試
  • 就業後

第5章美國雇主與職場藥物檢測市場：產品估計與趨勢分析

  • 細分儀表板
  • 美國雇主與職場藥物檢測市場、產品差異分析
  • 2021-2033 年美國雇主及職場藥物檢測市場規模及趨勢分析（依產品）
  • 耗材
  • 裝置
  • 快速檢測裝置
  • 服務

第6章美國雇主和職場藥物測試市場：模式估計和趨勢分析

  • 細分儀表板
  • 美國雇主與職場藥物檢測市場波動分析
  • 美國雇主和職場藥物檢測市場規模和趨勢分析（按模式）（2021-2033）
  • 尿
  • 頭髮
  • 口腔液體
  • 即時測試

第7章美國雇主和職場藥物檢測市場：藥物估計和趨勢分析

  • 細分儀表板
  • 美國雇主和職場藥物檢測市場的藥物波動分析
  • 美國雇主和職場藥物檢測市場規模和趨勢分析（按藥物，2021-2033 年）
  • 酒精
  • 大麻/大麻
  • 古柯鹼
  • 鴉片類藥物
  • 安非他命和甲基安非他命
  • LSD
  • 其他

第8章美國雇主和職場藥物測試市場：最終用途估計和趨勢分析

  • 細分儀表板
  • 美國雇主和職場藥物檢測市場的最終用途趨勢分析
  • 美國雇主與職場藥物檢測市場規模及趨勢分析（依最終用途），2021-2033 年
  • IT/金融
  • 製造業
  • 運輸
  • 建造
  • 零售和酒店
  • 衛生保健
  • 教育
  • 其他專業服務

第9章 競爭態勢

  • 公司/競爭對手分類
  • 戰略地圖
  • 2024年企業市場分析
  • 主要認證提供者/計畫所有者列表
  • 公司簡介/上市公司
    • First Advantage
    • Laboratory Corporation of America Holdings（Labcorp）
    • Dragerwerk AG &Co. KGaA
    • Bio-Rad Laboratories, Inc.
    • Abbott
    • Clinical Reference Laboratory Inc.
    • Quest Diagnostics
    • Cordant Health Solutions
    • DISA Global Solutions
    • HireRight, LLC
    • OraSure Technologies, Inc.
    • Psychemedics Corporation
    • Omega Laboratories
Product Code: GVR-4-68040-450-9

Market Size & Trends:

The U.S. employer and workplace drug testing market size was estimated at USD 2.57 billion in 2024 and is projected to reach USD 4.01 billion by 2033, growing at a CAGR of 5.2% from 2025 to 2033. The market is primarily driven by stringent workplace safety regulations, growing awareness of substance abuse risks, and the increasing adoption of preventive screening measures across various industries. Drug testing programs are widely implemented to detect the presence of illicit substances and misuse of prescription medications, while comprehensive screening protocols support compliance with federal and state requirements, promote productivity, and reduce workplace incidents.

The demand for pre-employment and random workplace testing is growing, supported by improvements in rapid testing kits, lab-based tests, and oral fluid testing methods. Digital result systems and automated reporting have made the process faster and more accurate, helping employers make quick hiring decisions and monitor staff more effectively. Changing cannabis laws in several states are also leading companies to adjust their testing policies to meet both compliance needs and evolving legal standards.

A national survey by American Addiction Centers in 2024 found that 15.3% of U.S. workers had worked under the influence of alcohol, while 2.9% admitted to being under the influence of illegal drugs. This shows the ongoing challenges faced by employers and highlights the need for strong drug testing policies to protect workplace safety and productivity.

The rising number of employees with substance use disorders (SUD) further increases the importance of workplace testing. Substance abuse can lead to lower productivity, more absenteeism, and higher rates of illness. It also harms employee morale and raises the risk of workplace accidents and injuries, which together cost U.S. businesses billions of dollars each year. These factors are expected to keep driving the demand for employer and workplace drug testing services across the country.

Overall, the U.S. employer and workplace drug testing market is experiencing steady innovation aimed at improving speed, accuracy, and ease of use. Advancements in testing methods, digital result management, and analytical tools are helping employers streamline screening processes while ensuring compliance with evolving regulations. The adoption of multi-panel and oral fluid testing, supported by cloud-based platforms and AI-driven analytics, is making it easier to detect a broader range of substances and identify potential issues early. These innovations are expected to strengthen workplace safety programs and support more effective workforce management in the years ahead.

U.S. Employer And Workplace Drug Testing Market Report Segmentation

This report forecasts revenue growth at country level and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the U.S. employer and workplace drug testing market on type, product, mode, drug and end-use:

  • Type Outlook (Revenue in USD Million, 2021 - 2033)
  • Pre-employment Drug Screens
  • Post-employment
  • Product Outlook (Revenue in USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
  • Mode Outlook (Revenue in USD Million, 2021 - 2033)
  • Consumables
  • Instruments
  • Rapid Testing Devices
  • Services
  • Drug Outlook (Revenue in USD Million, 2021 - 2033)
  • Alcohol
  • Cannabis/Marijuana
  • Cocaine
  • Opioids
  • Amphetamine & Methamphetamine
  • LSD
  • Others
  • End-use Outlook (Revenue in USD Million, 2021 - 2033)
  • IT/Finance
  • Manufacturing
  • Transportation
  • Construction
  • Retail and Hospitality
  • Healthcare
  • Education
  • Other Professional Services

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definitions
    • 1.2.1. Type Segment
    • 1.2.2. Product Segment
    • 1.2.3. Mode Segment
    • 1.2.4. Drug Segment
    • 1.2.5. End Use Segment
  • 1.3. Information analysis
    • 1.3.1. Market formulation & data visualization
  • 1.4. Data validation & publishing
  • 1.5. Information Procurement
    • 1.5.1. Primary Research
  • 1.6. Information or Data Analysis
  • 1.7. Market Formulation & Validation
  • 1.8. Market Model
  • 1.9. Total Market: CAGR Calculation
  • 1.10. Objectives
    • 1.10.1. Objective 1
    • 1.10.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. U.S. Employer and Workplace Drug Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Employer and Workplace Drug Testing Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Employer and Workplace Drug Testing Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. U.S. Employer and Workplace Drug Testing Market Type Movement Analysis
  • 4.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
  • 4.4. Pre-employment Drug Screens
    • 4.4.1. Pre-employment drug screens market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Post-employment
    • 4.5.1. Post-employment market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. U.S. Employer and Workplace Drug Testing Market: Product Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. U.S. Employer and Workplace Drug Testing Market Product Movement Analysis
  • 5.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
  • 5.4. Consumables
    • 5.4.1. Consumables market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Instruments
    • 5.5.1. Instruments market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Rapid Testing Devices
    • 5.6.1. Rapid testing devices market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.7. Services
    • 5.7.1. Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. U.S. Employer and Workplace Drug Testing Market: Mode Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. U.S. Employer and Workplace Drug Testing Market Mode Movement Analysis
  • 6.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Mode, 2021 to 2033 (USD Million)
  • 6.4. Urine
    • 6.4.1. Urine market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Hair
    • 6.5.1. Hair market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Oral Fluid
    • 6.6.1. Oral fluid market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.7. Instant testing
    • 6.7.1. Instant testing market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. U.S. Employer and Workplace Drug Testing Market: Drug Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. U.S. Employer and Workplace Drug Testing Market Drug Movement Analysis
  • 7.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by Drug, 2021 to 2033 (USD Million)
  • 7.4. Alcohol
    • 7.4.1. Alcohol market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Cannabis/Marijuana
    • 7.5.1. Cannabis/marijuana market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Cocaine
    • 7.6.1. Cocaine market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Opioids
    • 7.7.1. Opioids testing market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.8. Amphetamine & Methamphetamine
    • 7.8.1. Amphetamine & methamphetamine market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.9. LSD
    • 7.9.1. LSD market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.10. Others
    • 7.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. U.S. Employer and Workplace Drug Testing Market: End Use Estimates & Trend Analysis

  • 8.1. Segment Dashboard
  • 8.2. U.S. Employer and Workplace Drug Testing Market End Use Movement Analysis
  • 8.3. U.S. Employer and Workplace Drug Testing Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 8.4. IT/Finance
    • 8.4.1. IT/finance market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.5. Manufacturing
    • 8.5.1. Manufacturing market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.6. Transportation
    • 8.6.1. Transportation market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.7. Construction
    • 8.7.1. Construction market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.8. Retail and Hospitality
    • 8.8.1. Retail and hospitality market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.9. Healthcare
    • 8.9.1. Healthcare market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.10. Education
    • 8.10.1. Education surgical centers market estimates and forecasts 2021 to 2033 (USD Million)
  • 8.11. Other Professional Services
    • 8.11.1. Other Professional Services market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company/Competition Categorization
  • 9.2. Strategy Mapping
  • 9.3. Company Market Position Analysis, 2024
  • 9.4. List of Key Certification Providers/Scheme Owners
  • 9.5. Company Profiles/Listing
    • 9.5.1. First Advantage
      • 9.5.1.1. Company overview
      • 9.5.1.2. Financial performance
      • 9.5.1.3. Product benchmarking
      • 9.5.1.4. Strategic initiatives
    • 9.5.2. Laboratory Corporation of America Holdings (Labcorp)
      • 9.5.2.1. Company overview
      • 9.5.2.2. Financial performance
      • 9.5.2.3. Product benchmarking
      • 9.5.2.4. Strategic initiatives
    • 9.5.3. Dragerwerk AG & Co. KGaA
      • 9.5.3.1. Company overview
      • 9.5.3.2. Financial performance
      • 9.5.3.3. Product benchmarking
      • 9.5.3.4. Strategic initiatives
    • 9.5.4. Bio-Rad Laboratories, Inc.
      • 9.5.4.1. Company overview
      • 9.5.4.2. Financial performance
      • 9.5.4.3. Product benchmarking
      • 9.5.4.4. Strategic initiatives
    • 9.5.5. Abbott
      • 9.5.5.1. Company overview
      • 9.5.5.2. Financial performance
      • 9.5.5.3. Product benchmarking
      • 9.5.5.4. Strategic initiatives
    • 9.5.6. Clinical Reference Laboratory Inc.
      • 9.5.6.1. Company overview
      • 9.5.6.2. Financial performance
      • 9.5.6.3. Product benchmarking
      • 9.5.6.4. Strategic initiatives
    • 9.5.7. Quest Diagnostics
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Cordant Health Solutions
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. DISA Global Solutions
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. HireRight, LLC
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. OraSure Technologies, Inc.
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Psychemedics Corporation
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Omega Laboratories
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product benchmarking
      • 9.5.13.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 U.S. employer and workplace drug testing market, by type, 2021 - 2033 (USD Million)
  • Table 3 U.S. employer and workplace drug testing market, by product, 2021 - 2033 (USD Million)
  • Table 4 U.S. employer and workplace drug testing market, by mode, 2021 - 2033 (USD Million)
  • Table 5 U.S. employer and workplace drug testing market, by drug, 2021 - 2033 (USD Million)
  • Table 6 U.S. employer and workplace drug testing market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 U.S. employer and workplace drug testing market segmentation
  • Fig. 2 Data analysis models
  • Fig. 3 Market formulation and validation
  • Fig. 4 Data validating & publishing
  • Fig. 5 Market research process
  • Fig. 6 Information procurement
  • Fig. 7 Primary research
  • Fig. 8 Value-chain-based sizing & forecasting
  • Fig. 9 QFD modelling for market share assessment
  • Fig. 10 Market formulation & validation
  • Fig. 11 Commodity flow analysis
  • Fig. 12 Market outlook
  • Fig. 13 Segment snapshot-1
  • Fig. 14 Segment snapshot-2
  • Fig. 15 Competitive landscape snapshot
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 U.S. employer and workplace drug testing market: Type outlook key takeaways
  • Fig. 20 U.S. employer and workplace drug testing market: Type movement analysis
  • Fig. 21 Pre-employment drug screens market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 22 Post-employment market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 23 U.S. employer and workplace drug testing market: Product outlook key takeaways
  • Fig. 24 U.S. employer and workplace drug testing market: Product movement analysis
  • Fig. 25 Consumables market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Rapid testing devices market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 29 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 30 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 31 Urine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Hair market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Oral fluid market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Instant testing estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. employer and workplace drug testing market: Mode outlook key takeaways
  • Fig. 36 U.S. employer and workplace drug testing market: Mode movement analysis
  • Fig. 37 Alcohol market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Cannabis/marijuana market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Cocaine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 Opioids estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Amphetamine & methamphetamine market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 LSD market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Others market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 U.S. employer and workplace drug testing market: End Use outlook key takeaways
  • Fig. 45 U.S. employer and workplace drug testing market: End Use movement analysis
  • Fig. 46 IT/finance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Manufacturing market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Transportation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Construction estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Retail and hospitality market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Healthcare market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Education market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Other professional services market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Market participant categorization
  • Fig. 55 U.S. employer and workplace drug testing market position analysis, 2024
  • Fig. 56 Strategic framework